SARAH THIBODEAU: Open Payments
NPI 1285963959 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 17 payments from 11 companies in 2025. Trend: 2023 $17 · 2024 $16 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $121 |
| ABBVIE INC. | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| Lundbeck LLC | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Corium, LLC | 1 | $27 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: SPRAVATO, CAPLYTA, REXULTI, VRAYLAR, FANAPT, INGREZZA, Auvelity, Azstarys.
Industry payments across CT — which companies pay providers there.
